Your browser doesn't support javascript.
loading
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study.
Gianni, Luca; Bisagni, Giancarlo; Colleoni, Marco; Del Mastro, Lucia; Zamagni, Claudio; Mansutti, Mauro; Zambetti, Milvia; Frassoldati, Antonio; De Fato, Raffaella; Valagussa, Pinuccia; Viale, Giuseppe.
Afiliación
  • Gianni L; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: gianni.luca@hsr.it.
  • Bisagni G; IRCCS Arcispedale S Maria Nuova Azienda Ospedaliera di Reggio Emilia, Reggio Emilia, Italy.
  • Colleoni M; European Institute of Oncology, Milan, Italy.
  • Del Mastro L; Department of Medical Oncology, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy.
  • Zamagni C; SSD Medical Oncology Addari, Policlinico Sant'Orsola Malpighi, Bologna, Italy.
  • Mansutti M; Department of Oncology, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
  • Zambetti M; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.
  • Frassoldati A; Oncology, Azienda Ospedaliero Universitaria di Ferrara-Arcispedale Sant'Anna, Ferrara, Italy.
  • De Fato R; Fondazione Michelangelo, Milan, Italy.
  • Valagussa P; Fondazione Michelangelo, Milan, Italy.
  • Viale G; European Institute of Oncology, Milan, Italy.
Lancet Oncol ; 19(2): 249-256, 2018 02.
Article en En | MEDLINE | ID: mdl-29326029
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article